Unsupervised Learning Approach for Pathology-Based Subtyping and Staging Multiple System Atrophy
Objective: To develop a classification and staging system for multiple system atrophy (MSA) using data-driven disease progression modeling. Background: MSA exhibits varying degrees of degeneration…Explore cellular heterogeneities of orbitofrontal cortex in multiple system atrophy using spatial transcriptomics
Objective: To explore the spatial organization and cellular complexity of the orbitofrontal cortex (OFC) in multiple system atrophy (MSA) via spatial transcriptomic (SRT). Background: The…Combining alpha-synuclein PET and seeded amplification assays to improve the diagnostic accuracy of Multiple System Atrophy of the Parkinsonian subtype (MSA-P)
Objective: To determine whether the combination of spatial (PET [18F]ACI-12589) and conformational (skin seed amplification assay; SAA) a-syn data aids the early differential diagnosis of…Heterogeneity of multiple system atrophy with an analysis of the clinical case
Objective: Multiple system atrophy (MSA) is a rapidly progressive neurodegenerative disease clinically characterized by various combinations of Parkinsonism with resistance to levodopa, cerebellar, autonomic, and…Posterior Fossa Arachnoid Cysts In Two Patients With Suspected Multiple System Atrophy – Cerebellar Type
Objective: To describe two patients with posterior fossa arachnoid cysts later diagnosed with suspected multiple system atrophy – cerebellar type (MSA-C). Background: The diagnosis of…Systematic Review of Incidence and Prevalence Studies of Multiple System Atrophy
Objective: This study sought to systematically review the methods and results of previous incidence and prevalence studies of MSA. Background: High-quality incidence and prevalence studies…An in-vivo study of regional synaptic density loss in patients with Multiple System Atrophy using [11C]UCB-J PET molecular imaging.
Objective: We present preliminary, cross-sectional data, on the in-vivo evaluation of pre-synaptic terminal density in the brain of patients with Multiple System Atrophy (MSA) compared…Next-generation sequencing analysis of circulating microRNAs in multiple system atrophy
Objective: The discriminatory peripheral circulating small non-coding RNAs (sncRNAs) using next-generation sequencing (NGS) between patients of multiple system atrophy (MSA), Parkinson's disease (PD), and healthy controls…The pivotal difference in gut microbiota between multiple system atrophy and Parkinson’s disease
Objective: The knowledge gap between microbiome dysbiosis and pathogenesis of multiple system atrophy (MSA) remains. Background: Mounting evidence has found significant alterations in the gut…Expression profile of circRNA in peripheral blood mononuclear cells of patients with Parkinson’s disease and atypical parkinsonian syndromes
Objective: This study aimed to uncover circRNAs subsets with diagnostic potential for APS and iPD. Background: Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP)…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 7
- Next Page »